Expertise
Navigating the Opioid Reduction Landscape  |  October 3, 2019

The increasing number of opioid overdose deaths over the last decade has resulted in a public health response centered around thoughtful opioid prescribing practices and careful consideration of risk versus benefit when initiating opioids for pain treatment. In 2016, the Centers for Disease Control and Prevention (CDC) released guidelines around prescribing opioids for chronic pain,…

Read More ›
Proposed Changes to 42 CFR Part 2: What You Need to Know  |  September 30, 2019

Last month, the Department of Health and Human Services (HHS) proposed reforms that would revise the regulations governing patient records of substance use disorder and treatment that are subject to extra privacy laws. The current federal law, known as 42 CFR Part 2 (Confidentiality of Substance Use Disorder Patient Records regulation), predates the Health Insurance…

Read More ›
Five Barriers to MAT Access  |  August 28, 2019

A recent McKinsey and Co. study suggests the nationwide prevalence of opioid use disorder (OUD) could be upwards of four to six million people, significantly higher than government estimates. And despite progress toward increasing addiction treatment access, only 25% of those with OUD receive any kind of treatment and only half of those are still…

Read More ›
Five Challenges to Safe Opioid Prescribing  |  July 25, 2019

For health plans and providers, managing patients on opioids requires a delicate balance between the patient’s pain management needs and the risk of opioid misuse. We asked our clinical experts to highlight their biggest challenges to improving care for patients on opioids, and their answers reflect the changing pain management and addiction landscape. 1. Lack…

Read More ›
axial Takeaway: PAINWeekEnd Nashville 2019  |  June 7, 2019

By Holly Little, PharmD, Clinical Pharmacy Specialist, and Bethany Bedford, PharmD, BCACP, CPE, Principal, Clinical Advisor New Markets and Programs Constructed for the busy clinician, the PAINWeekEnd Regional Conference Series is a precursor to the renowned PAINWeek conference and brings certified medical education to healthcare professionals in all disciplines with an interest in pain management….

Read More ›
Higher Opioid Dose = Higher Surgical Spend & Worse Patient Outcomes  |  May 23, 2019

Roughly 40% of patients in need of knee, hip or shoulder joint replacement are prescribed opioids prior to surgery. However, preoperative opioid use is associated with worse patient outcomes, higher health plan costs, higher opioid use during the surgical hospital stay, and a lower likelihood of discontinuing opioids after surgery. In our most recent study…

Read More ›